Simplify Logo

Full-Time

Senior Manager

Clinical Pharmacology

Posted on 3/22/2024

Cerevel Therapeutics

Cerevel Therapeutics

201-500 employees

Develops neuroscience therapies for CNS disorders

Hardware
Biotechnology

Senior

Remote in USA

Category
Healthcare Administration & Support
Physicians & Surgeons
Medical, Clinical & Veterinary
Required Skills
Communications
Requirements
  • Experience supporting small molecule programs
  • Effective verbal and written communication skills
  • Hands-on experience in performing population PK and PKPD modelling using NONMEM/R or similar software
Responsibilities
  • Responsible for planning and executing state-of-art Clinical Pharmacology program and M&S strategy to support Cerevel portfolio including Go/No-go decision making and dose finding strategies
  • Oversee the design and protocol writing of clinical pharmacology studies (e.g., food effect, human ADME, drug-drug interactions, QTc, and hepatic/renal impairment)
  • Lead or Co-lead all quantitative pharmacology activities to support both regulatory filings and internal decision-making (e.g., Exposure-Response, QTc prolongation risk assessment, population PK/PD analysis) by working closely with internal colleagues (i.e. DMPK, toxicology, biology, clinical, statistics) and external vendors to advance programs from Phase I to late-stage development
  • Independently formulate clinical pharmacology strategy to support regulatory submissions
  • Establishing tools and methods which create opportunities for novel solutions
  • Anticipates potential multi-discipline problems and proposes innovative mitigation strategies
  • Manage external contract research organizations
  • Draft clinical pharmacology components of protocols, INDs, investigator's brochure and other regulatory documents
  • Provide ad-hoc support to other programs as needed

Cerevel Therapeutics is dedicated to developing experimental neuroscience therapies for central nervous system disorders, focusing on understanding neurocircuitry deficits to unlock new treatment opportunities.

Company Stage

IPO

Total Funding

$1.8B

Headquarters

Cambridge, Massachusetts

Founded

2018

Growth & Insights
Headcount

6 month growth

9%

1 year growth

11%

2 year growth

32%
INACTIVE